Table 1 Participant characteristics.
From: Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition
Melanoma | RCC | Carers | Total | ||
|---|---|---|---|---|---|
17 | 11 | 3 | 31 | ||
Gender | Female | 11 | 3 | 3 | 17 |
Male | 6 | 8 | 0 | 14 | |
Age range | 18–25 | 0 | 0 | 0 | 0 |
26–35 | 1 | 0 | 0 | 1 | |
36–45 | 3 | 1 | 0 | 4 | |
46–55 | 5 | 2 | 1 | 8 | |
56–65 | 5 | 7 | 1 | 13 | |
66–75 | 3 | 1 | 1 | 5 | |
>75 | 0 | 0 | 0 | 0 | |
Highest level of education | No qualification | 0 | 0 | 0 | 0 |
GCSE | 2 | 1 | 1 | 4 | |
NVQ | 1 | 0 | 0 | 1 | |
A level | 2 | 1 | 1 | 4 | |
Degree | 6 | 7 | 0 | 13 | |
Higher Degree | 4 | 2 | 1 | 7 | |
Other | 2 | 0 | 0 | 2 | |
Ethnicity | White | 17 | 10 | 3 | 30 |
Mixed | 0 | 0 | 0 | 0 | |
Asian | 0 | 0 | 0 | 0 | |
Black | 0 | 1 | 0 | 1 | |
Other | 0 | 0 | 0 | 0 | |
Dependents | Yes | 7 | 2 | 0 | 9 |
No | 10 | 9 | 3 | 22 | |
Time to travel to cancer centre (n = 3 carers not included) | <30 min | 5 | 6 | NA | 11 |
≥30 min <1 h | 7 | 3 | NA | 10 | |
≥1 h <2 h | 4 | 1 | NA | 5 | |
≥2 h | 1 | 1 | NA | 2 | |
Prior enrolment in a clinical trial (n = 3 carers not included) | Yes | 2 | 3 | NA | 5 |
No | 15 | 8 | NA | 23 | |
